about
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical UtilityThe biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humansGonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent mannermiR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression.Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells.GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies.GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cells.Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice.Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis.Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.Characterization of a soluble LHRH-degrading activity in the rat ventral prostateGrowth factors in steroid-responsive prostatic tumor cellsInhibition of DNA polymerization and DNA transcription to RNA by seminal plasma peptidesLuteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
P50
Q28078465-B4A1751B-540A-4A65-964F-7F5FD0067C1FQ28238916-FA39C355-B3F4-40ED-AB86-9F1DF3E9A455Q28537723-622377E3-5575-4540-B726-B8B740B9A411Q34952175-9F9151E3-915A-4E95-AD08-E8025F59501EQ35147098-80858CBF-F10F-4AB8-A05E-F711F6460D6BQ35725686-CD68B142-4F0C-4793-994F-9224F3E29CF1Q36482996-700B2F75-4EAD-4491-9167-69A86476D5A9Q37200271-914330AB-B7DF-4BBA-AA92-2864A3037944Q38025070-324576AE-6437-4644-B2A6-272FAF676ACFQ38682630-6971C338-4FBF-4924-98F5-F80113C0AC30Q39887963-59578583-521F-46D0-A88C-06DA562CB96FQ40059238-2090F4C4-4DC0-462F-A2A9-EE2AC120DC80Q40526407-C48A001C-A1C5-4A26-8146-4EA2286811E9Q40713266-4B3180B8-045C-4889-9443-E54E42CD7035Q40971129-036BB8E3-319F-4595-80D4-81513641D006Q41042189-215CE053-890E-4210-81B4-9A6D7C07B6A8Q41340606-ECEAB886-21CA-43EF-AB8B-4C5FDC609ADDQ42946229-D5B7FC89-5F7D-4DFE-AD5D-2CEDADB6CFC2Q48472838-2A7962E3-68F0-428D-B564-70784F8D7C70Q59613115-EA39C4CF-FD5E-459C-BB12-881CF89BF5ADQ59613139-820E7937-C518-4327-8405-7ABB5FD1E791Q60714551-D5D0E0BF-15B0-4C9C-AC8D-989BA696FB38Q71788622-819EBD36-C51D-4937-B8A7-ADFC708B55A6Q73179864-A5A90C7F-902E-4214-B024-4B06051FF672
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberta M Moretti
@ast
Roberta M Moretti
@en
Roberta M Moretti
@es
Roberta M Moretti
@nl
Roberta M Moretti
@sl
type
label
Roberta M Moretti
@ast
Roberta M Moretti
@en
Roberta M Moretti
@es
Roberta M Moretti
@nl
Roberta M Moretti
@sl
prefLabel
Roberta M Moretti
@ast
Roberta M Moretti
@en
Roberta M Moretti
@es
Roberta M Moretti
@nl
Roberta M Moretti
@sl
P1053
G-7514-2012
P106
P21
P31
P3829
P496
0000-0001-6456-5869